Klobuchar Michael A has filed 20 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 87157 shares of Eikon Therapeutics, Inc. ($EIKN) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Eikon Therapeutics, Inc. | $EIKN | Klobuchar Michael A | Chief Operating Officer | A | Stock Option (Right to Buy) | 87157 | $0.00 | 87,157.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2025 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 1338 | $0.00 | 5,088.0000 | 122,822,000 | 35.68% | 0.00% |
| April 30, 2025 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 1074 | $0.00 | 3,750.0000 | 122,822,000 | 40.13% | 0.00% |
| May 4, 2024 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Common Stock | 887 | $127.51 | 24,070.7790 | 2,547,000,000 | 3.83% | 0.00% |
| May 4, 2024 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | F | Common Stock | 437 | $127.51 | 23,633.7790 | 2,547,000,000 | 1.82% | 0.00% |
| May 4, 2024 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Restricted Stock Unit | 887 | $0.00 | 0.0000 | 2,547,000,000 | 100.00% | 0.00% |
| April 30, 2024 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | A | Stock Option (Right to Buy) | 20508 | $0.00 | 20,508.0000 | 2,547,000,000 | 9999.99% | 0.00% |
| May 1, 2024 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 977 | $0.00 | 1,458.0000 | 124,812,000 | 203.12% | 0.00% |
| May 1, 2024 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 1218 | $0.00 | 2,676.0000 | 124,812,000 | 83.54% | 0.00% |
| Feb. 15, 2024 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 217 | $0.00 | 217.0000 | 124,812,000 | 9999.99% | 0.00% |
| Feb. 15, 2024 | REVVITY, INC. | $RVTY | Klobuchar Michael A | Not found | A | Common Stock | 264 | $0.00 | 481.0000 | 124,812,000 | 121.66% | 0.00% |
| Jan. 22, 2024 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | A | Common Stock | 3896 | $119.43 | 23,110.7220 | 2,547,000,000 | 20.28% | 0.00% |
| May 4, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | F | Common Stock | 436 | $118.22 | 19,052.5830 | 2,542,000,000 | 2.24% | 0.00% |
| May 4, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Restricted Stock Unit | 885 | $0.00 | 887.0000 | 2,542,000,000 | 49.94% | 0.00% |
| May 4, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Common Stock | 885 | $118.22 | 19,488.5830 | 2,542,000,000 | 4.76% | 0.00% |
| May 2, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | A | Stock Option (Right to Buy) | 20747 | $0.00 | 20,747.0000 | 2,542,000,000 | 9999.99% | 0.00% |
| May 1, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Common Stock | 866 | $115.47 | 18,914.0450 | 2,542,000,000 | 4.80% | 0.00% |
| May 1, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | F | Common Stock | 427 | $115.47 | 18,603.5830 | 2,542,000,000 | 2.24% | 0.00% |
| May 1, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | M | Restricted Stock Unit | 866 | $0.00 | 0.0000 | 2,542,000,000 | 100.00% | 0.00% |
| Jan. 23, 2023 | Merck & Co., Inc. | $MRK | Klobuchar Michael A | EVP - Chief Strategy Officer | A | Common Stock | 2651 | $109.88 | 18,002.5140 | 2,542,000,000 | 17.27% | 0.00% |